GE HealthCare Technologies Inc. (GEHC)
| Market Cap | 36.05B |
| Revenue (ttm) | 19.56B |
| Net Income (ttm) | 1.68B |
| Shares Out | 456.87M |
| EPS (ttm) | 3.65 |
| PE Ratio | 21.62 |
| Forward PE | 17.41 |
| Dividend | $0.14 (0.18%) |
| Ex-Dividend Date | Jan 14, 2025 |
| Volume | 11,105,148 |
| Open | 77.02 |
| Previous Close | 77.43 |
| Day's Range | 76.89 - 79.03 |
| 52-Week Range | 71.31 - 94.55 |
| Beta | 1.27 |
| Analysts | Buy |
| Price Target | 95.46 (+20.97%) |
| Earnings Date | Feb 13, 2025 |
About GEHC
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health p... [Read more]
Financial Performance
In 2023, GEHC's revenue was $19.55 billion, an increase of 6.60% compared to the previous year's $18.34 billion. Earnings were $1.39 billion, a decrease of -27.71%.
Financial StatementsAnalyst Forecast
According to 13 analysts, the average rating for GEHC stock is "Buy." The 12-month stock price forecast is $95.46, which is an increase of 20.97% from the latest price.
News
2025 Could Be GE HealthCare's Year With Emphasis On Efficiency And AI Broadens
GE HealthCare shares have surged nearly 27% since October 2023, driven by AI-driven strategies and innovation in healthcare diagnostics, despite some volatility in revenue growth. The bullish outlook ...
GE HealthCare to announce fourth quarter and full year 2024 results on February 13, 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its fourth quarter and full year 2024 financial results before the market opens on Thursday, February 13, 2025. The GE HealthCare m...
GE HealthCare: Growth Acceleration In 2025 Can Drive Stock Higher
GE HealthCare Technologies is rated a buy due to strong growth prospects, a healthy backlog, and favorable valuation compared to peers. The company's revenue growth is supported by new product innovat...
GE HealthCare Expands Its Effortless Recon DL Portfolio, Bringing Advanced Deep Learning Image Reconstruction to Clinicians Worldwide
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) unveiled three new advanced deep learning image processing and reconstruction solutions as a part of its Effortless Recon DL portfolio at the Rad...
GE HealthCare showcases commitment to sustainable innovation at RSNA 2024
CHICAGO--(BUSINESS WIRE)--As part of a companywide commitment to advance innovation that improves the health of patients and the planet, GE HealthCare (Nasdaq: GEHC) is highlighting several solutions ...
Trade Tracker: Stephanie Link sells Lam Research, GE Healthcare and buys more Gap, CrowdStrike
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to reveal her latest portfolio moves.
GE HealthCare announces 510(k) submission for CleaRecon DL technology designed to improve image quality in the interventional suite with AI-based reconstruction
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep learning technology, designed to improve th...
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
CHALFONT ST GILES, England--(BUSINESS WIRE)--GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics (NMP), a leading radiopharmaceutical company in Japan, from Sumitomo Chemical.
GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today unveiled Sonic DL for 3Dii, the newest addition to its effortless imaging portfolio, designed to accelerate MRI scans across a wide range o...
GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024
CHICAGO--(BUSINESS WIRE)--At the Radiological Society of North America's (RSNA) 2024 Annual Meeting taking place from Dec. 1-4 in Chicago, GE HealthCare (Nasdaq: GEHC) will exhibit more than 40 innova...
GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care
CHICAGO--(BUSINESS WIRE)--Today GE HealthCare announced the new Pristina Via™* mammography system designed to enhance the screening experience for both technologists and patients. Debuting at the Radi...
GE HealthCare management to present at upcoming investor conferences
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. Nasdaq Investor Conference in Lond...
GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology
CHICAGO--(BUSINESS WIRE)--GE HealthCare announces additional clinical applications now available as part of the OEC 3D mobile CBCT C-arm portfolio.
GE HealthCare Guidance Was Good. The Stock Dropped Anyway.
GE HealthCare hosted an analyst event on Thursday. Solid guidance fell on deaf ears.
FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems
Expands accessibility for institutions utilizing GE HealthCare MRI systems Expands accessibility for institutions utilizing GE HealthCare MRI systems
GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will host its Investor Day today at Nasdaq MarketSite in New York, NY. The event begins at 8:00 am ET / 7:00 am CT and can be viewed virtually he...
Pilot Study Showcases the Value of Portrait Mobile Continuous Monitoring Solution to Encourage Clinical Intervention While Mitigating Alarm Fatigue
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the publication of data from a two-phase pilot study conducted with Cleveland Clinic in the peer-reviewed Journal of Clinical Ane...
GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner....
GE HealthCare Announces Initiative to Help Address Radiologic Technologist Shortage
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an initiative with AMN Healthcare aimed at helping address the critical shortage of radiologic technologists (rad tech) in the he...
GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™
CHICAGO--(BUSINESS WIRE)--Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), annou...
GE HealthCare Technologies Inc. Prices Secondary Offering of 13,281,302 Shares
CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offeri...
GE HealthCare Technologies Inc. Commences Secondary Offering of 13,281,302 Shares
CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 1...
GE HealthCare to Host its 2024 Investor Day on November 21
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will host its Investor Day on Thursday, November 21, 2024, at Nasdaq MarketSite in New York, NY, where its management team will present its growt...
GE HealthCare: Light Up With Growth Indicators In Medical Tech, While Undervalued
GE Healthcare Technologies gets a buy rating, agreeing with today's Wall Street and SA analyst consensus. The firm's recent Q3 results showed growth indicators in multiple segments, despite headwinds ...